Search

Your search keyword '"Loghavi, Sanam"' showing total 103 results

Search Constraints

Start Over You searched for: Author "Loghavi, Sanam" Remove constraint Author: "Loghavi, Sanam" Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
103 results on '"Loghavi, Sanam"'

Search Results

2. Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia

4. BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor

6. Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax

9. Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes

11. Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia

13. Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome

14. Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML

15. Undetectable Measurable Residual Disease is Associated with Improved Outcomes in AML Irrespective of Treatment Intensity

17. Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes

21. Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax

24. Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1

26. A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma

28. Detection of PNH Clones can Aid in the Distinction of Aplastic Anemia vs Inherited BM Failure Syndromes: A Single Center Experience and Review of the Literature

39. An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

42. AML-727 Clinical Characteristics and Outcomes of NUP98 Rearrangement in Adults with Acute Leukemia

44. Clinical Characteristics and Outcomes of NUP98 Rearrangement in Adults with Acute Leukemia

45. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

46. Phase I/II Study of Azacitidine (AZA) with Venetoclax (VEN) and Magrolimab (Magro) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High-Risk Acute Myeloid Leukemia (AML) and Relapsed/Refractory (R/R) AML

48. The Adverse Effect of Myelodysplasia-Related Mutations in De Novo Acute Myeloid Leukemia Is Associated with Higher Variant Allelic Frequency (VAF): A Proposal for a Numeric Cutoff for Variant Allelic Frequency

50. Non-Canonical FLT3 Mutations (FLT3m) in Patients (Pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) - Outcomes and Prognosis after FLT3 Inhibitor (FLT3i) and Venetoclax Based Regimens

Catalog

Books, media, physical & digital resources